Limbrel
Need help?
Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.
What Is Limbrel?
Limbrel is a brand-name prescription drug that was previously used for the management of osteoarthritis, a degenerative joint disease that causes pain, inflammation, and stiffness in the joints. It contained a proprietary blend of two active ingredients, flavocoxid and citrated zinc bisglycinate. However, it is important to note that Limbrel is currently unavailable in the United States. In 2017, the U.S. Food and Drug Administration (FDA) issued a mandatory recall of Limbrel due to safety concerns. There were reports of serious adverse events such as liver injury, hypersensitivity pneumonitis (lung inflammation), and other allergic reactions in patients taking the medication. As a result of these safety concerns, the manufacturer of Limbrel, Primus Pharmaceuticals, voluntarily ceased the distribution and sale of the drug. The FDA has advised healthcare professionals to stop prescribing Limbrel and has instructed patients to discontinue its use and seek alternative treatment options. It's important to consult with your healthcare provider for guidance on alternative medications or treatment strategies if you were previously prescribed Limbrel for osteoarthritis management.
How to use Limbrel?
Limbrel, a prescription drug used for managing osteoarthritis, is currently unavailable in the United States due to a mandatory recall by the FDA. Since 2017, the FDA has deemed it necessary to recall Limbrel from the market. As a result, the drug is not available for use by patients at this time. It's important to follow all recall notices and recommendations from the FDA and healthcare professionals regarding the use of Limbrel or any other recalled medication. If you have any questions or concerns about the availability or use of Limbrel, it's best to consult with your healthcare provider or pharmacist, as they will have the most up-to-date information on alternative treatment options for managing osteoarthritis.
Limbrel, a brand-name prescription drug used to manage osteoarthritis, has been subject to specific warnings associated with its use. However, it's important to note that Limbrel is currently unavailable in the United States due to a mandatory recall by the FDA that has been in effect since 2017. Prior to the recall, Limbrel carried warnings relating to potential adverse effects. Some individuals who took the medication reported experiencing serious liver injury, including jaundice, hepatitis, and liver failure. In some cases, these liver problems resulted in hospitalization or even the need for a liver transplant. Additionally, there were reports of hypersensitivity reactions such as rash, swelling, and difficulty breathing. These reactions can be severe and life-threatening in some cases. Considering the current unavailability of Limbrel, it is crucial for individuals who may have been using this medication to consult with their healthcare provider for alternative treatment options and to address any concerns they may have regarding the drug's prior warnings and recall.
Limbrel, which was marketed as a prescription drug for managing osteoarthritis, is currently not available in the United States. The FDA issued a mandatory recall in 2017 due to safety concerns. However, before the recall, there were warnings and precautions associated with the use of Limbrel that patients should have been aware of. Before taking Limbrel, it was important for patients to inform their healthcare provider about any existing medical conditions, such as liver disease or allergies, as well as all medications, supplements, and herbal products they were taking. This was crucial to prevent potential interactions or adverse reactions. Additionally, patients were advised to discontinue Limbrel and seek immediate medical attention if they experienced symptoms such as yellowing of the skin or eyes, dark urine, unusual tiredness, persistent nausea or vomiting, or abdominal pain. These symptoms could indicate a serious liver problem. It is essential to note that due to the current FDA recall, it is crucial not to take Limbrel or any existing supply of the medication. Patients should consult with their healthcare provider to explore alternative treatment options for managing osteoarthritis.
Limbrel, as a brand-name prescription drug, was primarily composed of two main active ingredients: bioflavonoids (from a proprietary blend of flavocoxid) and zinc. Flavocoxid is derived from a combination of plant-based substances, namely Scutellaria baicalensis and Acacia catechu. These ingredients have been marketed as having anti-inflammatory and antioxidant properties that could potentially help manage symptoms of osteoarthritis. However, it is worth mentioning that Limbrel is no longer available in the United States. The U.S. Food and Drug Administration (FDA) issued a mandatory recall in 2017 due to safety concerns associated with adverse drug reactions. As a result, the production and distribution of Limbrel have been halted, rendering it unavailable for use. It is essential for individuals who were previously prescribed Limbrel to consult with their healthcare provider regarding alternative treatment options. They should also stay updated with any developments regarding the availability of Limbrel or potential replacements.
Since Limbrel is currently unavailable in the United States due to a mandatory recall by the FDA in 2017, storage guidance for this medication is not applicable at this time. It is important to follow the FDA's recall guidelines and consult with healthcare professionals for alternative treatment options for managing osteoarthritis.